287 related articles for article (PubMed ID: 27391066)
41. Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
Li S; Zhu Y; Liang Z; Wang X; Meng S; Xu X; Xu X; Wu J; Ji A; Hu Z; Lin Y; Chen H; Mao Y; Wang W; Zheng X; Liu B; Xie L
Oncotarget; 2016 Aug; 7(32):51773-51783. PubMed ID: 27429046
[TBL] [Abstract][Full Text] [Related]
42. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
43. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
44. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
[TBL] [Abstract][Full Text] [Related]
45. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of CYLD downregulation in breast cancer.
Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.
Jiang L; Lin C; Song L; Wu J; Chen B; Ying Z; Fang L; Yan X; He M; Li J; Li M
J Clin Invest; 2012 Jan; 122(1):33-47. PubMed ID: 22156201
[TBL] [Abstract][Full Text] [Related]
48. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
49. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
50. miR-143 down-regulates TLR2 expression in hepatoma cells and inhibits hepatoma cell proliferation and invasion.
Liu X; Gong J; Xu B
Int J Clin Exp Pathol; 2015; 8(10):12738-47. PubMed ID: 26722463
[TBL] [Abstract][Full Text] [Related]
51. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
[TBL] [Abstract][Full Text] [Related]
52. Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma.
Xie D; Shang C; Zhang H; Guo Y; Tong X
Med Sci Monit; 2015 Jan; 21():225-30. PubMed ID: 25596753
[TBL] [Abstract][Full Text] [Related]
53. miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-κB feedback loops.
Wang T; Xu X; Xu Q; Ren J; Shen S; Fan C; Hou Y
Oncogene; 2017 Jun; 36(23):3240-3251. PubMed ID: 27991929
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
[TBL] [Abstract][Full Text] [Related]
55. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
56. miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops.
Song L; Lin C; Gong H; Wang C; Liu L; Wu J; Tao S; Hu B; Cheng SY; Li M; Li J
Cell Res; 2013 Feb; 23(2):274-89. PubMed ID: 23247627
[TBL] [Abstract][Full Text] [Related]
57. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective effects of isosteviol sodium through increasing CYLD by the downregulation of miRNA-181b.
Zhang H; Zhong K; Lu M; Mei Y; Tan E; Sun X; Tan W
Brain Res Bull; 2018 Jun; 140():392-401. PubMed ID: 29807144
[TBL] [Abstract][Full Text] [Related]
59. Possible role of nuclear factor kappaB detected by in situ hybridization in the pathogenesis of transitional cell carcinoma of the bladder.
Kadhim HS; Al-Jeboori TI; Tawfik MS
J Med Liban; 2006; 54(4):196-9. PubMed ID: 17330371
[TBL] [Abstract][Full Text] [Related]
60. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
